Modular design of artificial transcription factors

Current Opinion in Chemical Biology

Volumn 6, Issue 6, 2002, Pages 765-772

  Ansari, Aseem Z ^a   Mapp, Anna K ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PEPTIDE DERIVATIVE; TACROLIMUS; TRANSCRIPTION FACTOR;

DNA BINDING; EUKARYOTE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENE TARGETING; GENOMICS; NONHUMAN; PROTEIN DOMAIN; REVIEW; BIOTECHNOLOGY; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; EUKARYOTIC CELL; HUMAN; METABOLISM; METHODOLOGY; PROTEIN ENGINEERING; PROTEIN TERTIARY STRUCTURE;

EUKARYOTA;

BIOTECHNOLOGY; DRUG DESIGN; EUKARYOTIC CELLS; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTORS;

EID: 0036898867     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(02)00377-0     Document Type: Review

References (61)

1. Ptashne M., Gann A. Genes & Signals. 2001;Cold Spring Harbor Laboratory, New York. This book summarizes much that is known about transcriptional mechanisms, activators, repressors and the transcriptional machinery in an accessible format with many primary literature citations. The authors propose that 'regulated recruitment' is a guiding principle in most cellular processes.
2. Duncan S.A., Navas M.A., Dufort D., Rossant J., Stoffel M. Regulation of a transcription factor network required for differentiation and metabolism. Science. 281:1998;692-695.
3. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Aksien L.A., et al. Molecular portraits of human breast tumours. Nature. 406:2000;747-752.
4. Pandolfi P.P. Transcription therapy for cancer. Oncogene. 20:2001;3116-3127. This recent review discusses the relationship between disruption of a transcription factor and the onset of acute promyelocytic leukemia. It also proposes the use of ATFs as therapeutic agents for treatment of this disease.
5. Gottesfeld J.M., Turner J.M., Dervan P.B. Chemical approaches to control gene expression. Gene Expr. 9:2000;77-91.
6. Dervan P.B. Molecular recognition of DNA by small molecules. Bioorg Med Chem. 9:2001;2215-2235.
7. Denison C., Kodadek T. Small-molecule-based strategies for controlling gene expression. Chem Biol. 5:1998;R129-R145.
8. Ansari A.Z. Regulating gene expression: the design of synthetic transcriptional regulators. Curr Org Chem. 5:2001;903-921. This review outlines in detail the structure and function of natural and artificial transcriptional regulators. It contains an overview of the advantages and limitations of both protein and synthetic DBDs and a discussion of the current understanding of the structure-function relationship of RDs.
9. Mannervik M., Nibu Y., Zhang H., Levine M. Transcriptional coregulators in development. Science. 284:1999;606-609.
10. Smith R.L., Johnson A.D. Turning genes off by Ssn6-Tup1: a conserved system of transcriptional repression in eukaryotes. Trends Biochem Sci. 25:2000;325-330.
11. Garvie C.W., Wolberger C. Recognition of specific DNA sequences. Mol Cell. 8:2001;937-946. This recent review outlines the architectural principles governing protein-DNA interaction with relevant citations of the primary literature as well as other reviews on this topic.
12. Gerber H.P., Seipel K., Georgiev O., Hofferer M., Hug M., Rusconi S., Schaffner W. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science. 263:1994;808-811.
13. Courey A.J., Holtzman D.A., Jackson S.P., Tjian R. Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell. 59:1989;827-836.
14. Mermod N., Oneill E.A., Kelly T.J., Tjian R. The proline-rich transcriptional activator of Ctf/Nf-I is distinct from the replication and DNA-binding domain. Cell. 58:1989;741-753.
15. Saha S., Brickman J.M., Lehming N., Ptashne M. New eukaryotic transcriptional repressors. Nature. 363:1993;648-652.
16. Bentley D. Coupling RNA polymerase II transcription with pre-mRNA processing. Curr Opin Cell Biol. 11:1999;347-351.
17. Brown S.A., Weirich C.S., Newton E.M., Kingston R.E. Transcriptional activation domains stimulate initiation and elongation at different times and via different residues. EMBO J. 17:1998;3146-3154.
18. Blau J., Xiao H., McCracken S., Ohare P., Greenblatt J., Bentley D. Three functional classes of transcriptional activation domains. Mol Cell Biol. 16:1996;2044-2055.
19. Pabo C.O., Nekludova L. Geometric analysis and comparison of protein-DNA interfaces: why is there no simple code for recognition? J Mol Biol. 301:2000;597-624. The authors outline the problems that have been encountered in the numerous attempts to deduce a straightforward code for the recognition of DNA by proteins.
20. Urlinger S., Baron U., Thellmann M., Hasan M., Bujard H., Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA. 97:2000;7963-7968.
21. Chin J.W., Schepartz A. Concerted evolution of structure and function in a miniature protein. J Am Chem Soc. 123:2001;2929-2930. The authors describe a genetic selection with a novel minimal protein scaffold to obtain compact DBDs.
22. Beerli R.R., Barbas C.F. Engineering polydactyl zinc-finger transcription factors. Nat Biotechnol. 20:2002;135-141.
23. Neidle S. DNA minor-groove recognition by small molecules. Nat Prod Rep. 18:2001;291-309.
24. Faria M., Giovannangeli C. Triplex-forming molecules: from concepts to applications. J Gene Med. 3:2001;299-310.
25. Nielsen P.E. Peptide nucleic acid targeting of double-stranded DNA. Methods Enzymol. 340:2001;329-340.
26. Beerli R.R., Dreier B., Barbas C.F. Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci USA. 97:2000;1495-1500.
27. Liu P.Q., Rebar E.J., Zhang L., Liu Q., Jamieson A.C., Liang Y.X., Qi H., Li P.X., Chen B.L., Mendel M.C., et al. Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions - activation of vascular endothelial growth factor A. J Biol Chem. 276:2001;11323-11334.
28. Seipel K., Georgiev O., Schaffner W. A minimal transcription activation domain consisting of a specific array of aspartic-acid and leucine residues. Biol Chem Hoppe Seyler. 375:1994;463-470.
29. Yaghmai R., Cutting G.R. Optimized regulation of gene expression using artificial transcription factors. Mol Ther. 5:2002;685-694. This recent report outlines a systematic study of the regulatory potential of zinc-finger- based ATFs in a variety of cultured cell lines.
30. Kuznetsova S., Ait-Si-Ali S., Nagibneva I., Troalen F., Le Villain J.P., Harel-Bellan A., Svinarchuk F. Gene activation by triplex-forming oligonucleotide coupled to the activating domain of protein VP16. Nucleic Acids Res. 27:1999;3995-4000. This is the first report demonstrating that a TFO can be covalently conjugated to an activating region to generate an ATF that stimulates expression of a targeted reporter in cultured cell ines.
31. Stanojevic D., Young R.A. A highly potent artificial transcription factor. Biochemistry. 41:2002;7209-7216. A recent extension of [30•] in which the authors observe that adding a flexible linker between the TFO and the activating region increases the potency of the ATF.
32. Mapp A.K., Ansari A.Z., Ptashne M., Dervan P.B. Activation of gene expression by small molecule transcription factors. Proc Natl Acad Sci USA. 97:2000;3930-3935. This is the first demonstration of the idea that each component of a natural transcriptional regulator can be replaced with a synthetic counterpart to yield an ATF that functions well in an in vitro system. Perhaps most relevant for ATF design, it was observed that the length and composition of the linker has a profound effect on the potency of the ATF.
33. Ansari A.Z., Mapp A.K., Nguyen D.H., Dervan P.B., Ptashne M. Towards a minimal motif for artificial transcriptional activators. Chem Biol. 8:2001;583-592.
34. Nyanguile O., Uesugi M., Austin D.J., Verdine G.L. A nonnatural transcriptional coactivator. Proc Natl Acad Sci USA. 94:1997;13402-13406.
35. Ma J., Ptashne M. A new class of yeast transcriptional activators. Cell. 51:1987;113-119.
36. Lu X.Y., Ansari A.Z., Ptashne M. An artificial transcriptional activating region with unusual properties. Proc Natl Acad Sci USA. 97:2000;1988-1992. The authors report the isolation of 'non-acidic' octapeptides that function as well as the strongest natural yeast activators. As such, they are the smallest eukaryotic artificial activators.
37. Frangioni J.V., LaRiccia L.M., Cantley L.C., Montminy M.R. Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening. Nat Biotechnol. 18:2000;1080-1085.
38. Han Y., Kodadek T. Peptides selected to bind the Ga180 repressor are potent transcriptional activation domains in yeast. J Biol Chem. 275:2000;14979-14984.
39. Sengupta D.J., Wickens M., Fields S. Identification of RNAs that bind to a specific protein using the yeast three-hybrid system. RNA. 5:1999;596-601.
40. Fisher A.L., Caudy M. Groucho proteins: transcriptional corepressors for specific subsets of DNA-binding transcription factors in vertebrates and invertebrates. Genes Dev. 12:1998;1931-1940.
41. Andrulis E.D., Neiman A.M., Appulla D.C., Sternglanz R. Perinuclear localization of chromatin facilitates transcriptional silencing. Nature. 394:1998;592-595.
42. Dickinson L.A., Gulizia R.J., Trauger J.W., Baird E.E., Mosier D.E., Gottesfeld J.M., Dervan P.B. Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands. Proc Natl Acad Sci USA. 95:1998;12890-12895.
43. Janssen S., Cuvier O., Muller M., Laemmli U.K. Specific gain- and loss-of-function phenotypes induced by satellite-specific DNA-binding drugs fed to Drosophila melanogaster. Mol Cell. 6:2000;1013-1024. In this elegant study, the authors use polyamide-based ATFs to induce phenotypic changes in D. melanogaster. Here, the ATF functioned in an organism rather than in cultured cell lines.
44. Cutrona G., Carpaneto E.M., Ulivi M., Roncella S., Landt O., Ferrarini M., Boffa L.C. Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat Biotechnol. 18:2000;300-303. The authors demonstrate that covalent attachment of a nuclear localization sequence to a PNA results in transport into cells and nuclei. The NLS does, however, appear to interfere with the ability of the PNA to target its specific DNA site.
45. Boffa L.C., Scarfi S., Mariani M.R., Damonte G., Allfrey V.G., Benatti U., Morris P.L. Dihydrotestosterone as a selective cellular/nuclear localization vector for anti-gene peptide nucleic acid in prostatic carcinoma cells. Cancer Res. 60:2000;2258-2262.
46. Supekova L., Pezacki J.P., Su A.I., Loweth C.J., Riedl R., Geierstanger B., Schultz P.G., Wemmer D.E. Genomic effects of polyamide/DNA Interactions on mRNA expression. Chem Biol. 9:2002;821-827. The authors used genome-wide transcript profiling in colon cancer cells to investigate the targeting specificity of a polyamide ATF designed to inhibit an endogenous gene. They conclude that transcript profiling will be an important tool in future design efforts.
47. Zhang B., Kraemer B., Sengupta D.J., Fields S., Wickens M. Yeast three-hybrid system to detect and analyze interactions between RNA and protein. Methods Enzymol. 306:1999;93-113.
48. Lin H., Cornish V.W. In vivo protein-protein interaction assays: beyond proteins. Angew Chem. 40:2001;871-875.
49. Belshaw P.J., Ho S.N., Crabtree G.R., Schreiber S.L. Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci USA. 93:1996;4604-4607.
50. Arora PS, Ansari AZ, Best T, Ptashne M, Dervan PB: Design of artificial transcriptional activators with rigid poly-l-proline linkers. J Am Chem Soc 2002, in press.
51. Baron U., Bujard H. Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol. 327:2000;401-421.
52. Altoff E.A., Cornish V.W. A bacterial small-molecule three-hybrid system. Angew Chem Int Ed Engl. 41:2002;2327-2330.
53. Beerli R.R., Schopfer U., Dreier B., Barbas C.F. Chemically regulated zinc finger transcription factors. J Biol Chem. 275:2000;32617-32627. This study represents a first step in designing ATFs that can be used to regulate gene expression in a temporal manner. This approach offers much promise for the design of ATFs that respond to one or more physiological cues (Fig. 4).
54. Belitsky J.M., Leslie S.J., Arora P.S., Beerman T.A., Dervan P.B. Cellular uptake of N-methylpyrrole/N-methylimidazole polyamide-dye conjugates. Bioorg Med Chem. 10:2002;3313-3318. In this recent report, the authors examined the cellular uptake of fluorescently labeled polyamides in seven different cell lines and observed that five cell lines showed no discernable nuclear localization of the conjugates. Also noteworthy is the observation that cell fixing caused rapid uptake into the nuclei of all cell types examined, indicating the importance of live cell controls.
55. Schwarze S.R., Dowdy S.F. In vivo protein transduction: intracellular delivery of biologically active proteins. compounds and DNA. Trends Pharmacol Sci. 21:2000;45-48.
56. Hawiger J. Noninvasive intracellular delivery of functional peptides and proteins. Curr Opin Chem Biol. 3:1999;89-94.
57. Rothbard J.B., Kreider E., VanDeusen C.L., Wright L., Wylie B.L., Wender P.A. Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J Med Chem. 45:2002;3612-3618.
58. Torgerson T.R., Colosia A.D., Donahue J.P., Lin Y.Z., Hawiger J. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50. J Immunol. 161:1998;6084-6092.
59. Marmorstein R., Carey M., Ptashne M., Harrison S.C. DNA recognition by GAL4 - structure of a protein·DNA complex. Nature. 356:1992;408-415.
60. Wang B.S., Grant R.A., Pabo C.O. Selected peptide extension contacts hydrophobic patch on neighboring zinc finger and mediates dimerization on DNA. Nat Struct Biol. 8:2001;589-593.
61. Kielkopf C.L., White S., Szewczyk J.W., Turner J.M., Baird E.E., Dervan P.B., Rees D.C. A structural basis for recognition of A·T and T·A base pairs in the minor groove of B-DNA. Science. 282:1998;111-115.